Linamar Corp
LNR
ISIN null / Valor 692660
Linamar Corp
UMushroom community rating:
About company
Linamar Corp is a diversified global manufacturing company headquartered in Canada, known for its expertise in precision manufacturing and advanced technology solutions. The company operates across various sectors, including automotive, industrial, and medical markets. Linamar MedTech, a division of the company, focuses on producing innovative and cost-effective medical products and complex device assemblies, leveraging Linamar's extensive global supply chain, logistics, and quality systems. The facilities dedicated to the medical market adhere to ISO 13485:2016 standards, ensuring high-quality manufacturing processes. Beyond the medical sector, Linamar is recognized for its contributions to the automotive industry, providing components and systems that enhance vehicle performance and efficiency. The company's commitment to integrating cutting-edge technology with manufacturing expertise positions it as a key player in powering vehicles, motion, and work solutions globally.
Summarized from source with an LLMView SourceSector: IndustrialsLatest Results (28.02.2026):
Linamar Corporation — Q1 2025: Linamar delivered earnings growth and stronger cash generation in a challenging market. Sales fell to $2,532.1M (down 7.0% y/y) but normalized operating earnings rose 3.4% to $252.0M, normalized diluted EPS increased 6.6% to $2.76, and the company generated $76.4M of free cash flow while boosting liquidity to $1.82B.
Key financials
Sales: $2,532.1M (Q1 2025 vs $2,721.9M Q1 2024). GAAP operating earnings $266.3M; net earnings $177.7M (diluted EPS $2.94). Normalized operating earnings $252.0M (+3.4%); normalized net earnings $167.2M (+4.8%). Normalized operating margin ~10.0%; normalized net margin 6.6%.
Cash flow & liquidity
Free cash flow of $76.4M in Q1 2025 (improvement of $115.7M y/y). Cash and equivalents $909.2M and available credit $913.4M for total reported liquidity of $1.82B (up ~39.1% vs Q1 2024).
Capital return & dividend
Share repurchases: 1.0M shares repurchased in Q1 2025 (1.8M total since NCIB start in Nov 2024). Dividend: quarterly dividend increased to CAD$0.29 per share (declared for quarter ended March 31, 2025; payable on/after June 6, 2025).
Segment performance
Industrial: normalized operating earnings up 5.3% to $126.6M, normalized margins 20.0% (sales down 13.1% to $633.4M, driven by weaker access equipment and agriculture markets but offset by market share gains and the Bourgault acquisition). Mobility: normalized operating earnings up 1.5% to $125.4M, normalized margins ~6.6% (sales down 4.7% to $1,898.7M, affected by lower automotive volumes, including EV programs; benefits from cost reductions and FX).
Margin drivers & items of note
Gross margin improved to 15.9% (from 14.4%) driven by cost reductions, operational efficiencies, reduced launch costs, customer recoveries and FX benefits. Amortization rose (6.1% of sales) due to new launches and acquisition-related assets. SG&A was flat y/y. Finance expense declined (lower debt and interest rates); effective tax rate increased to 26.4% (impacted by foreign tax mix and Pillar 2).
Risks and other commentary
Management notes minimal material impact from tariffs to date (products remain USMCA compliant) but flags ongoing trade and macro risks. The release contains forward‑looking statements and reconciliations of non‑GAAP measures. Summarized from source with an LLMView Source
Key figures
Performance
Volatility
3611 M
Market cap (USD)
82,765
Daily traded volume (Shares)
56.86 / 55.85
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
